List of Tables
Table 1. Global Drug Coated Stent System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Drug Coated Stent System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Drug Coated Stent System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Drug Coated Stent System Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Drug Coated Stent System Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Drug Coated Stent System Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Drug Coated Stent System Sales by Region (2020-2025) & (K Units)
Table 8. Global Drug Coated Stent System Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Drug Coated Stent System Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Drug Coated Stent System Sales Share by Manufacturers (2020-2025)
Table 12. Global Drug Coated Stent System Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Drug Coated Stent System Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Drug Coated Stent System by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Coated Stent System as of 2024)
Table 16. Global Drug Coated Stent System Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Drug Coated Stent System Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Drug Coated Stent System Manufacturing Base and Headquarters
Table 19. Global Drug Coated Stent System Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Drug Coated Stent System Sales by Type (2020-2025) & (K Units)
Table 23. Global Drug Coated Stent System Sales by Type (2026-2031) & (K Units)
Table 24. Global Drug Coated Stent System Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Drug Coated Stent System Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Drug Coated Stent System ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Drug Coated Stent System Sales by Application (2020-2025) & (K Units)
Table 29. Global Drug Coated Stent System Sales by Application (2026-2031) & (K Units)
Table 30. Drug Coated Stent System High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Drug Coated Stent System Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Drug Coated Stent System Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Drug Coated Stent System ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Drug Coated Stent System Growth Accelerators and Market Barriers
Table 37. North America Drug Coated Stent System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Drug Coated Stent System Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Drug Coated Stent System Growth Accelerators and Market Barriers
Table 40. Europe Drug Coated Stent System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Drug Coated Stent System Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Drug Coated Stent System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Drug Coated Stent System Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Drug Coated Stent System Growth Accelerators and Market Barriers
Table 45. Southeast Asia Drug Coated Stent System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Drug Coated Stent System Investment Opportunities and Key Challenges
Table 47. Central and South America Drug Coated Stent System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Drug Coated Stent System Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Drug Coated Stent System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. QualiMe Corporation Information
Table 51. QualiMe Description and Major Businesses
Table 52. QualiMe Product Models, Descriptions and Specifications
Table 53. QualiMe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. QualiMe Sales Value Proportion by Product in 2024
Table 55. QualiMe Sales Value Proportion by Application in 2024
Table 56. QualiMe Sales Value Proportion by Geographic Area in 2024
Table 57. QualiMe Drug Coated Stent System SWOT Analysis
Table 58. QualiMe Recent Developments
Table 59. Medtronic Corporation Information
Table 60. Medtronic Description and Major Businesses
Table 61. Medtronic Product Models, Descriptions and Specifications
Table 62. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Medtronic Sales Value Proportion by Product in 2024
Table 64. Medtronic Sales Value Proportion by Application in 2024
Table 65. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 66. Medtronic Drug Coated Stent System SWOT Analysis
Table 67. Medtronic Recent Developments
Table 68. Cardionovum Corporation Information
Table 69. Cardionovum Description and Major Businesses
Table 70. Cardionovum Product Models, Descriptions and Specifications
Table 71. Cardionovum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Cardionovum Sales Value Proportion by Product in 2024
Table 73. Cardionovum Sales Value Proportion by Application in 2024
Table 74. Cardionovum Sales Value Proportion by Geographic Area in 2024
Table 75. Cardionovum Drug Coated Stent System SWOT Analysis
Table 76. Cardionovum Recent Developments
Table 77. MicroPort Corporation Information
Table 78. MicroPort Description and Major Businesses
Table 79. MicroPort Product Models, Descriptions and Specifications
Table 80. MicroPort Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. MicroPort Sales Value Proportion by Product in 2024
Table 82. MicroPort Sales Value Proportion by Application in 2024
Table 83. MicroPort Sales Value Proportion by Geographic Area in 2024
Table 84. MicroPort Drug Coated Stent System SWOT Analysis
Table 85. MicroPort Recent Developments
Table 86. P+F Products + Features GmbH Corporation Information
Table 87. P+F Products + Features GmbH Description and Major Businesses
Table 88. P+F Products + Features GmbH Product Models, Descriptions and Specifications
Table 89. P+F Products + Features GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. P+F Products + Features GmbH Sales Value Proportion by Product in 2024
Table 91. P+F Products + Features GmbH Sales Value Proportion by Application in 2024
Table 92. P+F Products + Features GmbH Sales Value Proportion by Geographic Area in 2024
Table 93. P+F Products + Features GmbH Drug Coated Stent System SWOT Analysis
Table 94. P+F Products + Features GmbH Recent Developments
Table 95. Boston Scientific Corporation Information
Table 96. Boston Scientific Description and Major Businesses
Table 97. Boston Scientific Product Models, Descriptions and Specifications
Table 98. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Boston Scientific Recent Developments
Table 100. Abbott Corporation Information
Table 101. Abbott Description and Major Businesses
Table 102. Abbott Product Models, Descriptions and Specifications
Table 103. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Abbott Recent Developments
Table 105. Biotronik Corporation Information
Table 106. Biotronik Description and Major Businesses
Table 107. Biotronik Product Models, Descriptions and Specifications
Table 108. Biotronik Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Biotronik Recent Developments
Table 110. USM Healthcare Corporation Information
Table 111. USM Healthcare Description and Major Businesses
Table 112. USM Healthcare Product Models, Descriptions and Specifications
Table 113. USM Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. USM Healthcare Recent Developments
Table 115. Concept Medical Inc Corporation Information
Table 116. Concept Medical Inc Description and Major Businesses
Table 117. Concept Medical Inc Product Models, Descriptions and Specifications
Table 118. Concept Medical Inc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Concept Medical Inc Recent Developments
Table 120. MicroPort Scientific Corporation Corporation Information
Table 121. MicroPort Scientific Corporation Description and Major Businesses
Table 122. MicroPort Scientific Corporation Product Models, Descriptions and Specifications
Table 123. MicroPort Scientific Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. MicroPort Scientific Corporation Recent Developments
Table 125. Lepu Medical Technology Corporation Information
Table 126. Lepu Medical Technology Description and Major Businesses
Table 127. Lepu Medical Technology Product Models, Descriptions and Specifications
Table 128. Lepu Medical Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Lepu Medical Technology Recent Developments
Table 130. JW Medical Systems Corporation Information
Table 131. JW Medical Systems Description and Major Businesses
Table 132. JW Medical Systems Product Models, Descriptions and Specifications
Table 133. JW Medical Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. JW Medical Systems Recent Developments
Table 135. SINOMED Corporation Information
Table 136. SINOMED Description and Major Businesses
Table 137. SINOMED Product Models, Descriptions and Specifications
Table 138. SINOMED Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. SINOMED Recent Developments
Table 140. Kinhely Bio-Tech Corporation Information
Table 141. Kinhely Bio-Tech Description and Major Businesses
Table 142. Kinhely Bio-Tech Product Models, Descriptions and Specifications
Table 143. Kinhely Bio-Tech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Kinhely Bio-Tech Recent Developments
Table 145. Shandong Huaan Biotechnology Corporation Information
Table 146. Shandong Huaan Biotechnology Description and Major Businesses
Table 147. Shandong Huaan Biotechnology Product Models, Descriptions and Specifications
Table 148. Shandong Huaan Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Shandong Huaan Biotechnology Recent Developments
Table 150. Blue Sail Medical Corporation Information
Table 151. Blue Sail Medical Description and Major Businesses
Table 152. Blue Sail Medical Product Models, Descriptions and Specifications
Table 153. Blue Sail Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Blue Sail Medical Recent Developments
Table 155. Shanghai Bio-heart Biological Technology Corporation Information
Table 156. Shanghai Bio-heart Biological Technology Description and Major Businesses
Table 157. Shanghai Bio-heart Biological Technology Product Models, Descriptions and Specifications
Table 158. Shanghai Bio-heart Biological Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Shanghai Bio-heart Biological Technology Recent Developments
Table 160. Key Raw Materials Distribution
Table 161. Raw Materials Key Suppliers
Table 162. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 163. Milestones in Production Technology Evolution
Table 164. Distributors List
Table 165. Market Trends and Market Evolution
Table 166. Market Drivers and Opportunities
Table 167. Market Challenges, Risks, and Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Coated Stent System Product Picture
Figure 2. Global Drug Coated Stent System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Rapamycin Coated Stent Product Picture
Figure 4. Ivimox Coated Bracket Product Picture
Figure 5. Paclitaxel Coated Stent Product Picture
Figure 6. Zothamos Coated Bracket Product Picture
Figure 7. Global Drug Coated Stent System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Drug Coated Stent System Report Years Considered
Figure 12. Global Drug Coated Stent System Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Drug Coated Stent System Revenue (2020-2031) & (US$ Million)
Figure 14. Global Drug Coated Stent System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Drug Coated Stent System Revenue Market Share by Region (2020-2031)
Figure 16. Global Drug Coated Stent System Sales (2020-2031) & (K Units)
Figure 17. Global Drug Coated Stent System Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Drug Coated Stent System Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Drug Coated Stent System Sales Volume Market Share in 2024
Figure 20. Global Drug Coated Stent System Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Rapamycin Coated Stent Revenue Market Share by Manufacturer in 2024
Figure 23. Ivimox Coated Bracket Revenue Market Share by Manufacturer in 2024
Figure 24. Paclitaxel Coated Stent Revenue Market Share by Manufacturer in 2024
Figure 25. Zothamos Coated Bracket Revenue Market Share by Manufacturer in 2024
Figure 26. Global Drug Coated Stent System Sales Market Share by Type (2020-2031)
Figure 27. Global Drug Coated Stent System Revenue Market Share by Type (2020-2031)
Figure 28. Global Drug Coated Stent System Sales Market Share by Application (2020-2031)
Figure 29. Global Drug Coated Stent System Revenue Market Share by Application (2020-2031)
Figure 30. North America Drug Coated Stent System Sales YoY (2020-2031) & (K Units)
Figure 31. North America Drug Coated Stent System Revenue YoY (2020-2031) & (US$ Million)
Figure 32. North America Top 5 Manufacturers Drug Coated Stent System Sales Revenue (US$ Million) in 2024
Figure 33. North America Drug Coated Stent System Sales Volume (K Units) by Type (2020- 2031)
Figure 34. North America Drug Coated Stent System Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 35. North America Drug Coated Stent System Sales Volume (K Units) by Application (2020-2031)
Figure 36. North America Drug Coated Stent System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 37. US Drug Coated Stent System Revenue (2020-2031) & (US$ Million)
Figure 38. Canada Drug Coated Stent System Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico Drug Coated Stent System Revenue (2020-2031) & (US$ Million)
Figure 40. Europe Drug Coated Stent System Sales YoY (2020-2031) & (K Units)
Figure 41. Europe Drug Coated Stent System Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Europe Top 5 Manufacturers Drug Coated Stent System Sales Revenue (US$ Million) in 2024
Figure 43. Europe Drug Coated Stent System Sales Volume (K Units) by Type (2020-2031)
Figure 44. Europe Drug Coated Stent System Sales Revenue (US$ Million) by Type (2020-2031)
Figure 45. Europe Drug Coated Stent System Sales Volume (K Units) by Application (2020-2031)
Figure 46. Europe Drug Coated Stent System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. Germany Drug Coated Stent System Revenue (2020-2031) & (US$ Million)
Figure 48. France Drug Coated Stent System Revenue (2020-2031) & (US$ Million)
Figure 49. U.K. Drug Coated Stent System Revenue (2020-2031) & (US$ Million)
Figure 50. Italy Drug Coated Stent System Revenue (2020-2031) & (US$ Million)
Figure 51. Russia Drug Coated Stent System Revenue (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Drug Coated Stent System Sales YoY (2020-2031) & (K Units)
Figure 53. Asia-Pacific Drug Coated Stent System Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Top 8 Manufacturers Drug Coated Stent System Sales Revenue (US$ Million) in 2024
Figure 55. Asia-Pacific Drug Coated Stent System Sales Volume (K Units) by Type (2020- 2031)
Figure 56. Asia-Pacific Drug Coated Stent System Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 57. Asia-Pacific Drug Coated Stent System Sales Volume (K Units) by Application (2020-2031)
Figure 58. Asia-Pacific Drug Coated Stent System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Indonesia Drug Coated Stent System Revenue (2020-2031) & (US$ Million)
Figure 60. Japan Drug Coated Stent System Revenue (2020-2031) & (US$ Million)
Figure 61. South Korea Drug Coated Stent System Revenue (2020-2031) & (US$ Million)
Figure 62. China Taiwan Drug Coated Stent System Revenue (2020-2031) & (US$ Million)
Figure 63. India Drug Coated Stent System Revenue (2020-2031) & (US$ Million)
Figure 64. Central and South America Drug Coated Stent System Sales YoY (2020-2031) & (K Units)
Figure 65. Central and South America Drug Coated Stent System Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Manufacturers Drug Coated Stent System Sales Revenue (US$ Million) in 2024
Figure 67. Central and South America Drug Coated Stent System Sales Volume (K Units) by Type (2021-2031)
Figure 68. Central and South America Drug Coated Stent System Sales Revenue (US$ Million) by Type (2020-2031)
Figure 69. Central and South America Drug Coated Stent System Sales Volume (K Units) by Application (2020-2031)
Figure 70. Central and South America Drug Coated Stent System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Brazil Drug Coated Stent System Revenue (2020-2025) & (US$ Million)
Figure 72. Argentina Drug Coated Stent System Revenue (2020-2025) & (US$ Million)
Figure 73. Middle East, and Africa Drug Coated Stent System Sales YoY (2020-2031) & (K Units)
Figure 74. Middle East and Africa Drug Coated Stent System Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Middle East and Africa Top 5 Manufacturers Drug Coated Stent System Sales Revenue (US$ Million) in 2024
Figure 76. Middle East and Africa Drug Coated Stent System Sales Volume (K Units) by Type (2021-2031)
Figure 77. South America Drug Coated Stent System Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Middle East and Africa Drug Coated Stent System Sales Volume (K Units) by Application (2020-2031)
Figure 79. Middle East and Africa Drug Coated Stent System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. GCC Countries Drug Coated Stent System Revenue (2020-2025) & (US$ Million)
Figure 81. Turkey Drug Coated Stent System Revenue (2020-2025) & (US$ Million)
Figure 82. Egypt Drug Coated Stent System Revenue (2020-2025) & (US$ Million)
Figure 83. South Africa Drug Coated Stent System Revenue (2020-2025) & (US$ Million)
Figure 84. Drug Coated Stent System Industry Chain Mapping
Figure 85. Regional Drug Coated Stent System Manufacturing Base Distribution (%)
Figure 86. Global Drug Coated Stent System Production Market Share by Region (2020-2031)
Figure 87. Drug Coated Stent System Production Process
Figure 88. Regional Drug Coated Stent System Production Cost Structure
Figure 89. Channels of Distribution (Direct Vs Distribution)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
